Sclerostin inhibition alleviates breast cancer–induced bone metastases and muscle weaknessEric Hesse(LMU Klinikum), Hanna Taipaleenmäki(LMU Klinikum)JCI InsightApril 9, 201910.1172/jci.insight.125543Cited by 113SaveCiteExport RISWatch citationsRelated PapersAntagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells|Oncotarget|2016|87TG-interacting factor 1 (Tgif1)-deficiency attenuates bone remodeling and blunts the anabolic response to parathyroid hormone|Nature Communications|2019|53